FDA Inspection 938861 — Montefiore's Institute For Reproductive Medicine And Health

Montefiore's Institute For Reproductive Medicine And Health — FEI 3003972343

The FDA completed an inspection of Montefiore's Institute For Reproductive Medicine And Health on Aug 10, 2015 in Hartsdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 10, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Hartsdale, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1227121 CFR 1271.65(b)(2)Prominently labeled (limited use)
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1228221 CFR 1271.75(d)Donors with risks not determined ineligible

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.